SAN FRANCISCO-- Cardica Inc. shares rocketed up 68% to $8.80 in Monday morning trade after the Redwood City, Calif.-based company said it has received 510(k) clearance from the Food and Drug Administration to market its C-Port xA distal anastomosis system in the U.S. The company said the C-Port xA system automates the creation of anastomoses, or attachments of blood vessels and grafts, such as those in coronary artery bypass graft surgeries.
What is an anastomosis? It's the literal stitching together of two blood vessels done by the surgeon. It is time consuming and tedious. This machine then does the ligation of two blood vessels together by inserting minute staples into the vessel walls. The resulting junctions are leak proof and can fluctuate with blood flow. It will mainly be used in coronary atertery diseased patients and graft insertions. Very Cool indeed.!
CRDC shares shot up 36% today to close at $7.17 on heavy trading.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment